Is AI/ML Bringing Medicines To Patients Faster And Cheaper?
Source: Life Science Leader
By Hettie Stroebel
Mathematician Alan Turing changed history in 1950 with a simple question: “Can machines think?”
The phrase artificial intelligence (AI) was coined in 1956, yet the pharmaceutical industry embraced artificial intelligence and machine learning (ML) only about 15 to 20 years ago as a technology for use in drug discovery and drug development. It is critical to move beyond simply using AI as a buzzword and instead determine if AI/ML does indeed change the discovery and clinical development process by bringing innovation to patients faster and at a lower investment.
VIEW THE MAGAZINE ARTICLE! Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.
Subscribe to Life Science Leader X
Subscribe to Life Science Leader